The Prague Post - US panel weighs authorizing Covid vaccines for youngest children

EUR -
AED 4.313975
AFN 80.547545
ALL 97.434934
AMD 449.73046
ANG 2.102303
AOA 1077.171324
ARS 1492.791377
AUD 1.764031
AWG 2.116752
AZN 2.0016
BAM 1.955498
BBD 2.367734
BDT 143.357833
BGN 1.955498
BHD 0.442932
BIF 3495.35953
BMD 1.174668
BND 1.502568
BOB 8.102747
BRL 6.532923
BSD 1.172619
BTN 101.493307
BWP 15.744565
BYN 3.837607
BYR 23023.499991
BZD 2.355536
CAD 1.60865
CDF 3393.617337
CHF 0.926897
CLF 0.028411
CLP 1114.547663
CNY 8.403625
CNH 8.419418
COP 4775.561579
CRC 592.408399
CUC 1.174668
CUP 31.128712
CVE 110.247953
CZK 24.57048
DJF 208.817712
DKK 7.463496
DOP 71.148999
DZD 152.157473
EGP 57.684081
ERN 17.620026
ETB 163.190867
FJD 2.634488
FKP 0.874805
GBP 0.867394
GEL 3.18381
GGP 0.874805
GHS 12.254105
GIP 0.874805
GMD 84.57654
GNF 10176.42647
GTQ 9.000608
GYD 245.342064
HKD 9.220266
HNL 30.706252
HRK 7.537617
HTG 153.886205
HUF 396.850416
IDR 19217.339549
ILS 3.93908
IMP 0.874805
INR 101.611755
IQD 1536.162471
IRR 49468.226083
ISK 142.276286
JEP 0.874805
JMD 187.051077
JOD 0.832886
JPY 173.446879
KES 151.506573
KGS 102.553011
KHR 4697.273684
KMF 491.603168
KPW 1057.221015
KRW 1625.318589
KWD 0.358662
KYD 0.977249
KZT 639.001194
LAK 25279.09122
LBP 105069.953557
LKR 353.815291
LRD 235.113646
LSL 20.812382
LTL 3.468491
LVL 0.710546
LYD 6.330021
MAD 10.545169
MDL 19.72395
MGA 5179.199166
MKD 61.550483
MMK 2465.733848
MNT 4216.363074
MOP 9.481134
MRU 46.800763
MUR 53.342135
MVR 18.094285
MWK 2033.385588
MXN 21.777064
MYR 4.958867
MZN 75.131746
NAD 20.812382
NGN 1799.510154
NIO 43.153327
NOK 11.93722
NPR 162.388891
NZD 1.948849
OMR 0.45182
PAB 1.172619
PEN 4.153358
PGK 4.860248
PHP 67.132737
PKR 332.301418
PLN 4.249143
PYG 8783.641829
QAR 4.274539
RON 5.067641
RSD 117.131888
RUB 93.035614
RWF 1695.037905
SAR 4.407599
SBD 9.732239
SCR 16.61843
SDG 705.392672
SEK 11.192362
SGD 1.503815
SHP 0.923105
SLE 26.959075
SLL 24632.212956
SOS 670.196371
SRD 43.067458
STD 24313.263549
STN 24.496212
SVC 10.260413
SYP 15272.941179
SZL 20.804783
THB 38.024448
TJS 11.198868
TMT 4.123086
TND 3.423471
TOP 2.751195
TRY 47.634334
TTD 7.973767
TWD 34.632517
TZS 3004.935362
UAH 49.031718
UGX 4204.349902
USD 1.174668
UYU 46.972737
UZS 14837.70572
VES 141.281363
VND 30711.704452
VUV 140.295141
WST 3.217414
XAF 655.855588
XAG 0.030777
XAU 0.000352
XCD 3.1746
XCG 2.113373
XDR 0.815674
XOF 655.855588
XPF 119.331742
YER 283.036769
ZAR 20.86834
ZMK 10573.429114
ZMW 27.351771
ZWL 378.242735
  • RBGPF

    -1.1200

    73.88

    -1.52%

  • SCU

    0.0000

    12.72

    0%

  • SCS

    0.0700

    10.58

    +0.66%

  • CMSD

    0.0400

    22.89

    +0.17%

  • NGG

    -0.0800

    72.15

    -0.11%

  • RELX

    -0.9800

    52.73

    -1.86%

  • VOD

    -0.0900

    11.43

    -0.79%

  • CMSC

    0.0550

    22.485

    +0.24%

  • BCC

    1.7100

    88.14

    +1.94%

  • RYCEF

    -0.0400

    13.2

    -0.3%

  • RIO

    -0.7300

    63.1

    -1.16%

  • JRI

    -0.0600

    13.09

    -0.46%

  • BCE

    -0.2300

    24.2

    -0.95%

  • GSK

    -0.2600

    37.97

    -0.68%

  • AZN

    -1.0200

    72.66

    -1.4%

  • BP

    0.0700

    32.2

    +0.22%

  • BTI

    -0.3700

    52.25

    -0.71%

US panel weighs authorizing Covid vaccines for youngest children
US panel weighs authorizing Covid vaccines for youngest children / Photo: Frederic J. BROWN - AFP/File

US panel weighs authorizing Covid vaccines for youngest children

After months of anxious wait for some parents, a panel of experts convened by the US Food and Drug Administration will meet Wednesday to weigh recommending Covid vaccines for the nation's youngest children.

Text size:

Children under five are the only age group not yet eligible for Covid immunization in the United States and most other countries. If, as expected, panelists vote in favor of greenlighting the Pfizer and Moderna vaccines, formal authorizations should follow quickly, with the first shots in arms expected by next week.

Ahead of the meeting, the FDA posted its independent analyses of the two drugs, deeming both safe and effective. It also said there was a pressing unmet need to inoculate children in the age group since their rates of hospitalization and death "are higher than among children and adolescents 5-17 years of age."

Both vaccines are based on messenger RNA technology, which delivers genetic code for the coronavirus spike protein to human cells, training the immune system to be ready for when it encounters the real virus.

Pfizer is seeking authorization for three doses at three micrograms given to ages six months through four years, while Moderna has asked for the FDA to approve its vaccine as two doses of a higher 30 micrograms, for ages six months through five years.

They were tested in trials of thousands of children where they were found to have similar levels of mild effects to older age groups and triggered similar levels of antibodies.

Efficacy against infection was higher for Pfizer, with the company placing it at 80 percent compared to Moderna's estimates of 51 percent in the six-month-old to age two group and 37 percent in the two to five years age group.

But the figures are provisional and Moderna is studying adding a third dose later that may increase its figures.

There are some 20 million US children aged four years and under. If the FDA-appointed experts recommend the two vaccines, then the matter will go to another committee convened by the Centers for Disease Control and Prevention for a final say.

White House officials last week said the rollout of millions of shots at pharmacies and doctors' offices could begin as soon as June 21, following the Juneteenth holiday on June 20.

Of the total US Covid deaths, 480 have come in children under five, according to the latest official data.

Obesity, neurological disorders and asthma are associated with increased risk of severe disease, "however, a majority of children hospitalized for Covid-19 have no underlying medical conditions," the FDA said in a document.

Children can also go on to contract multisystem inflammatory syndrome in children (MIS-C), a rare but serious post-viral condition.

Data on long Covid in children is sparse, but the FDA's document cited a national survey in the United Kingdom which found that "among children ages two to 11 years who tested positive for COVID-19, 7.2 percent reported continued symptoms at 12 weeks."

J.Simacek--TPP